The high tumorigenicity of this cell line is also associated with the overexpression of several tumor markers, including ROR2 and FGFR, and it showed sensitivity to irreversible pan-ErbB inhibitors and DNA alkylating agents. The gene discussed is ROR2; the disease is neoplasm.